Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL699496 | 0.87 | TSHR (0.35) | ALDH1A1LMNANPSR1HSD17B10SMN1; SMN2 | |
| SCHEMBL10357730 | 0.83 | TP53 (0.41) | ALDH1A1LMNANPSR1HSD17B10TP53 | |
| SCHEMBL335798 | 0.81 | TP53 (0.36) | ALDH1A1LMNANPSR1HSD17B10TP53 | |
| Biphenyl SCHEMBL4386676 | 0.81 | MMP2 (0.37) | LMNATP53KDM4ESMN1; SMN2 | |
| SCHEMBL10587125 | 0.77 | ALDH1A1 (0.41) | ALDH1A1LMNANPSR1HSD17B10TP53 | |
| Propylamine SCHEMBL3388064 | 0.76 | TP53 (0.36) | ALDH1A1LMNANPSR1HSD17B10TP53 | |
| Octane SCHEMBL18395350 | 0.76 | DNM1 (0.44) | TP53SMN1; SMN2 | |
| Ethylamine SCHEMBL2230804 | 0.75 | TP53 (0.39) | ALDH1A1LMNANPSR1HSD17B10TP53 | |
| SCHEMBL5089460 | 0.75 | ALDH1A1 (0.39) | ALDH1A1LMNANPSR1HSD17B10TP53 | |
| Methylene Chloride SCHEMBL14786034 | 0.75 | ALDH1A1 (0.39) | ALDH1A1LMNANPSR1HSD17B10TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4509515-B1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, AND CATALYST COMPOSITION COMPRISING SAME | LG CHEMICAL LTD (KR) | 2026-04-29 | — | — | EP | disclosed |
| EP-4215537-B1 | LIGAND COMPOUND, ORGANOCHROMIUM COMPOUND, AND CATALYST SYSTEM COMPRISING THE SAME | LG CHEMICAL LTD (KR) | 2026-04-29 | — | — | EP | disclosed |
| EP-4700033-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND AND CATALYST COMPOSITION COMPRISING SAME | LG Chem, Ltd. (KR) | 2026-02-25 | — | — | EP | disclosed |
| EP-4700031-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, AND CATALYST COMPOSITION COMPRISING SAME | LG Chem, Ltd. (KR) | 2026-02-25 | — | — | EP | disclosed |
| US-20250381558-A1 | Ligand Compound, Organic Chromium Compound, and Catalyst Compositions Containing the Same | LG CHEM, LTD. (KR) | 2025-12-18 | — | — | US | disclosed |
| EP-4559921-B1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND AND CATALYST COMPOSITION COMPRISING SAME | LG CHEMICAL LTD (KR) | 2025-11-26 | — | — | EP | disclosed |
| US-20250333427-A1 | Ligand Compound, Organic Chromium Compound, and Catalyst Composition Including the Same | LG CHEM, LTD. (KR) | 2025-10-30 | — | — | US | disclosed |
| EP-4559921-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND AND CATALYST COMPOSITION COMPRISING SAME | LG Chem, Ltd. (KR) | 2025-05-28 | — | — | EP | disclosed |
| US-20250100953-A1 | Ligand Compound, Organochromium Compound and Catalyst Composition Comprising the Same | LG CHEM, LTD. (KR) | 2025-03-27 | — | — | US | disclosed |
| EP-4509515-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, AND CATALYST COMPOSITION COMPRISING SAME | LG Chem, Ltd. (KR) | 2025-02-19 | — | — | EP | disclosed |
| US-20240287223-A1 | Ligand Compound, Organochromium Compound and Catalyst Composition Comprising the Same | LG CHEM, LTD. (KR) | 2024-08-29 | — | — | US | disclosed |
| WO-2024071940-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND AND CATALYST COMPOSITION COMPRISING SAME | 주식회사 엘지화학 | 2024-04-04 | — | — | WO | disclosed |
| EP-4342903-A1 | LIGAND COMPOUND, ORGANIC CHROME COMPOUND, AND CATALYST COMPOSITION COMPRISING SAME | Lg Chem, Ltd. (KR) | 2024-03-27 | — | — | EP | disclosed |
| CN-117529486-A | Ligand compound, organic chromium compound, and catalyst composition comprising same | 株式会社LG化学 | 2024-02-06 | — | — | CN | disclosed |
| US-20230331753-A1 | Ligand Compound, Organochromium Compound and Catalyst System Comprising the Same | LG CHEM, LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| WO-2023177130-A1 | LIGAND COMPOUND, ORGANIC CHROME COMPOUND, AND CATALYST COMPOSITION COMPRISING SAME | 주식회사 엘지화학 | 2023-09-21 | — | — | WO | disclosed |
| WO-2023177129-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND AND CATALYST COMPOSITION COMPRISING SAME | 주식회사 엘지화학 | 2023-09-21 | — | — | WO | disclosed |
| EP-4215537-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, AND CATALYST SYSTEM COMPRISING SAME | Lg Chem, Ltd. (KR) | 2023-07-26 | — | — | EP | disclosed |
| CN-115989233-A | Ligand compound, organic chromium compound and catalyst system comprising same | 株式会社LG化学 | 2023-04-18 | — | — | CN | disclosed |
| WO-2022060108-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, AND CATALYST SYSTEM COMPRISING SAME | 주식회사 엘지화학 | 2022-03-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250100953-A1 | Ligand Compound, Organochromium Compound and Catalyst Composition Comprising the Same | OXER1, ESR1, NOD1 | ALDH1A1 3829/4885LMNA 4055/4885NPSR1 1443/4885 |
| US-20250333427-A1 | Ligand Compound, Organic Chromium Compound, and Catalyst Composition Including the Same | OXER1, ORC3, CRKL | ALDH1A1 3554/4885LMNA 3442/4885NPSR1 3575/4885 |
| US-20230331753-A1 | Ligand Compound, Organochromium Compound and Catalyst System Comprising the Same | ETV6, ESR1, OXER1 | ALDH1A1 4271/4885LMNA 4350/4885NPSR1 507/4885 |
| US-20250381558-A1 | Ligand Compound, Organic Chromium Compound, and Catalyst Compositions Containing the Same | EXOC1, OXER1, ORC3 | ALDH1A1 3116/4885LMNA 3425/4885NPSR1 3656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.